123 related articles for article (PubMed ID: 6169492)
1. A new concept on the natural course of hepatocellular carcinoma.
Tang ZY
Chin Med J (Engl); 1981 Sep; 94(9):585-8. PubMed ID: 6169492
[No Abstract] [Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma with cirrhosis: the initial experience and a preliminary report from the University of Ghent, Belgium.
Troisi R; Praet M; Defreyne L; Elewaut A; Hesse UJ; Pattyn P; Decruyenaere J; De Hemptinne B
Transplant Proc; 1994 Dec; 26(6):3570-1. PubMed ID: 7527980
[No Abstract] [Full Text] [Related]
3. Impact of staging on the treatment of hepatocellular carcinoma.
Zornig C; Broelsch CE
Endoscopy; 1993 Jan; 25(1):138-42. PubMed ID: 7681000
[No Abstract] [Full Text] [Related]
4. Current status of treatment of hepatocellular carcinoma.
Tang ZY
Chin Med J (Engl); 1985 Apr; 98(4):257-64. PubMed ID: 2408825
[No Abstract] [Full Text] [Related]
5. More options and improved outcomes for hepatocellular carcinoma.
Scoggins CR
J Surg Oncol; 2008 Aug; 98(2):74. PubMed ID: 18623036
[No Abstract] [Full Text] [Related]
6. Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens.
Duvoux C; Cherqui D; Van Nhieu JT; Vavasseur D; Zafrani ES; Mathieu D; Fagniez PL; Dhumeaux D
Transplant Proc; 1994 Dec; 26(6):3572-3. PubMed ID: 7527981
[No Abstract] [Full Text] [Related]
7. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
Rizzi PM; Ryder SD; Ramage JK; Gane E; Karani J; Heaton N; Portmann B; Tan KC; Williams R
Transplant Proc; 1994 Dec; 26(6):3568-9. PubMed ID: 7527979
[No Abstract] [Full Text] [Related]
8. Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease.
Strebel BM; Dufour JF
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1743-9. PubMed ID: 18983234
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Yoshioka H; Sato M; Sonomura T; Terada M; Kishi K; Yoshikawa A
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
[TBL] [Abstract][Full Text] [Related]
10. Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
Huo TI; Lee SD
Liver Int; 2006 Dec; 26(10):1300-1. PubMed ID: 17105599
[No Abstract] [Full Text] [Related]
11. [Progress in the diagnosis and treatment of small hepatocellular carcinoma].
Tan ZQ
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):733-5. PubMed ID: 7541324
[No Abstract] [Full Text] [Related]
12. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
Schumacher G; Gebauer B
J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
[No Abstract] [Full Text] [Related]
13. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
[TBL] [Abstract][Full Text] [Related]
14. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
[TBL] [Abstract][Full Text] [Related]
15. [The role of alpha-1-fetoprotein in the diagnosis of primary hepatocellular carcinoma and some teratogenic tumors].
Balogh T; Bajtai G; Ambrus M; Pár A; Palka I
Orv Hetil; 1980 Sep; 121(39):2371-4. PubMed ID: 6162145
[No Abstract] [Full Text] [Related]
16. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
[TBL] [Abstract][Full Text] [Related]
17. [Subclinical hepatocellular carcinoma].
Tang ZY
Zhonghua Zhong Liu Za Zhi; 1983 May; 5(3):226-8. PubMed ID: 6194949
[No Abstract] [Full Text] [Related]
18. [Current therapeutic strategies in hepatocellular carcinoma, Part 1].
Wallner I; Hartmann H; Ramadori G
Leber Magen Darm; 1994 Jul; 24(4):150, 153-4. PubMed ID: 7934608
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].
Kudo M; Chung H; Osaki Y; Kasugai H; Oka H; Seki T
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2100-4. PubMed ID: 15628751
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
